Le Lézard
Classified in: Health
Subjects: SVY, PET

Veterinary Lasers Market: Attractive Investment Opportunities Exist in Latin America North America Continues to Dominate: Global Industry Analysis (2013 - 2017) and Opportunity Assessment (2018 - 2028)


NEW YORK, Sept. 11, 2018 /PRNewswire/ -- According to the latest research, the US$ 123.2 Mn global veterinary lasers market is apprehended to reach beyond US$ 336 Mn by the end of 2028. The market for veterinary lasers is foreseen to witness robust growth over a 10-year projection period 2018-2028, at a CAGR of 9.7%. Primarily driven by growing pet ownership, the market will also gain traction due to growing demand for laser therapies in both surgical and therapeutic procedures.

Read the full report: https://www.reportlinker.com/p05503579

North America to Remain at the Forefront; Latin America to Emerge Most Attractive Market

The regional analysis of the global market for veterinary lasers highlights continued dominance of North America, followed by Latin America. North America registered a market value share of more than 26% in 2017, which is expected to stay dominant throughout the forecast period. In terms of growth, North America's market is anticipated to thrive at the fastest CAGR of 10.8% between 2018 and 2028. Increasing pet ownership and soaring awareness about maintaining pet healthcare will collectively fuel the sales of veterinary lasers in North America. This regional market will continue to be led by the US throughout the forecast period.

Latin America, the second largest market for veterinary lasers, will also remain the second fastest growing region with a robust CAGR of 10.2% over the assessment period. By product type, therapeutic laser segment is expected to stay dominant, while by laser type, class 3 segment is presumed to be dominant. By end-user, clinics are anticipated to account for the largest value share of the total revenues in 2028. Increasing prevalence of acute and chronic ailments in animals, followed by decent rise in adoption of imaging devices and equipment, is likely to spur the demand for veterinary lasers in the Latin American region. Owing to earlier and higher penetration of pet care, the pet care market in Latin America is expected to present the most attractive investment opportunities to leading animal healthcare device manufacturers. Moreover, significantly growing demand for non-invasive procedures, growing number of veterinary healthcare facilities, and impressively flourishing markets in Brazil and Mexico will also provide a major thrust to market growth in this region.

Europe is expected to experience a CAGR of over 9% during 2018-2028, whereas developing regions (other than Latin America) will reportedly see CAGRs of above 8%. In a nutshell, all the regional markets across the globe are likely to witness healthy growth over the forecast period.

Therapeutic Laser to Lead by Product Type, Class 3 Laser to Dominate by Laser Type, and Hospitals to Top by End-user

By product type, therapeutic laser segment registered dominance in the global veterinary lasers market in terms of revenue in 2017, and the trend is projected to continue throughout the forecast period. By 2028 end, therapeutic laser segment is estimated to cross a value worth US$ 140 Mn, followed by surgical laser segment - the second key segment in the veterinary laser market. Therapeutic and surgical (combined) will be the most attractive segment estimated to thrive at 10.5% CAGR over the forecast period. Based on laser type, class 3 segment has been dominant over class 2 and class 4 segments. In terms of volume, consumption of class 3 lasers will possibly exceed 20,000 units by the end of 2028. The assessment period is expected to observe robust growth of class 4 laser segment at a CAGR of over 10%. On the basis of end-user, adoption of veterinary lasers by hospitals has been the highest over the years but the next few years are likely to see maximum adoption of veterinary lasers by clinics, in terms of end-user.

Read the full report: https://www.reportlinker.com/p05503579

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 14:00
Sojournix, a clinical-stage biopharmaceutical company dedicated to developing and commercializing transformative new medicines for the treatment of women's health and neuroendocrine disorders, today presented positive data from a first-in-human Phase...

at 14:00
Oral semaglutide 7 mg and 14 mg demonstrated superior HbA1c and body weight reductions compared to Januvia® (sitagliptin 100 mg). Non-inferiority for oral semaglutide 3 mg for HbA1c reductions at 26 weeks was not confirmed. Presented today at the...

at 13:00
Highway West Vacations has announced its first annual Borrego Wellness Weekend for April 19 - 21, 2019. Health and nature enthusiasts will explore guided mindfulness and hiking in the blooming California desert, learn healthy cooking behavior, and...

at 09:33
Health Canada is advising Canadians that Baxter Corporation is voluntarily recalling two lots of Extraneal peritoneal dialysis solution as a precautionary measure because of high levels of sodium hypochlorite. Use of the affected product in patients...

at 09:05
The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes, but it is actually unable to detect the disease in most patients, according to a new study presented Saturday, March 23, at a news conference at...

at 09:00
Sanbio B.V., an independent supplier and manufacturer of MONOSAN® products for research, and BenchSci, a life science machine learning company backed by Google's AI fund, have entered into a partnership to provide scientists with high-quality...



News published on 11 september 2018 at 10:03 and distributed by: